FutureWorld (FWDG) Subsidiary CB Scientific Signs Distribution Agreement with UTest

CB Scientific to make its THC & CBD Test Kits for UTest for Global Distribution

St. Petersburg, Florida, UNITED STATES

ST. PETERSBURG, FL, March 16, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTC: FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announced that CB Scientific, a subsidiary of FutureWorld Corp., has reached a definitive distribution agreement with ÜTest. The agreement makes CB Scientific's "Product of the Year", PersonalAnalytics THC & CBD Home Test Kits available through ÜTest. ÜTest has served the diagnostic needs of North America since 1996. Using instant analysis technologies, their original focus was to provide diagnostic products for law enforcement, probation and parole officers. ÜTest now offers a complete line of reliable, do-it-yourself drug testing kits for parents and employers and are used by rehabilitation clinics, drug courts, doctor offices, pre-employment screening and drug testing for theme parks, ski resorts, and oil fields of North America. ÜTest's current product line dove-tails nicely with CB Scientific's THC & CBD Test Kits. 

The agreement between CB Scientific and ÜTest will make THC & CBD potency test kits available through ÜTest. The distribution agreement also includes the new "Double Kit" (Test Kits that can run 2 tests vs only 1) which CB Scientific will launch in coming days. "We recognize a need to expand sales and grow as quickly as possible and providing a "ÜTest version" of our kits helps us put the award winning Test Kits in more hands almost immediately!" "Working directly with a proven leader in 'On-the-Spot' testing allows CB Scientific to extend its product reach and take a dramatic step to meet our truly global aspirations." comments Bill Short, CEO of CB Scientific.

CB Scientific's PersonalAnalytics are the first tests for consumers that are available for personal use to test for cannabinoids, including THC and CBD, outside of a lab setting. These affordable and high-quality tests provide results in ten minutes or less, and have numerous uses for recreational and medical purposes, including patients who need to use medical cannabis and hemp-related products such as CBD oil.

The tests have been featured on ABC, CBS, Fox, Telemundo, The Adam Dunn Show, as well as in publications such as High Times, Culture and Forbes Magazine. In December 2014, just 94 days after its launch the THC & CBD Test Kits were awarded "Product of the Year" by the Cannabis Business Awards in Colorado.

This distribution deal with ÜTest is expected to add thousands of kits per month to company sales.

About CB Scientific

CB Scientific (www.cbscientific.com) is a wholly owned company of FutureWorld Corp. based in Denver, Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis analytics. The senior management team are some of the primary men advancing gas chromatography testing in Colorado having pioneered residual solvent testing for medical cannabis and always striving to help patients know exactly what they are buying. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution. CB Scientific has worked with many of the cannabis industry leaders in Colorado and have also been featured in cannabis industry publications including High Times Magazine, Culture and many trade publications, on-air interviews and panel discussions across the United States.

CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.

To request further information about CB Scientific, please email us at info@cbscientific.com, log onto our website at http://www.cbscientific.com or visit us on Twitter @CBscientific.

About FutureWorld Corp.

FutureWorld (Other OTC: FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. 

To request further information about FutureWorld, please email us at info@futureworldcorp.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page facebook.com/futureworldenergy or on Twitter @futureworldinc. 

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.